Push 29080 records
29,080 records0 files14 MiB total4 types
| id | nctId | title | status | sponsorId | briefSummary | completionDate | conditions | enrollmentCount | enrollmentType | phase | startDate | studyType | url | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00000171 | NCT00000171 | Study of Melatonin: Sleep Problems in Alzheimer's Disease | COMPLETED | national-institute-on-aging-nia | This protocol is a multicenter clinical trial of melatonin for sleep disturbances associated with Alzheimer's disease (AD). Frequent nocturnal awakening is a common behavioral symptom of AD. Nighttime… | — | ["Alzheimer Disease","Dyssomnias"] | — | — | PHASE3 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000171 | |
| NCT00000172 | NCT00000172 | Placebo Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy Under a Slow-Titration Regimen | COMPLETED | janssen-lp | Galantamine is an experimental drug being evaluated in the United States for the treatment of Alzheimer's disease. Results from previous clinical trials suggest that galantamine may improve cognitive … | — | ["Alzheimer Disease"] | — | — | PHASE3 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000172 | |
| NCT00000173 | NCT00000173 | A Randomized, Double-Blind, Placebo-Controlled Trial of Vitamin E and Donepezil HCL (Aricept) to Delay Clinical Progression From Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) | COMPLETED | national-institute-on-aging-nia | The National Institute on Aging (NIA) is launching a nationwide treatment study targeting individuals with mild cognitive impairment (MCI), a condition characterized by a memory deficit, but not demen… | 2004-01 | ["Alzheimer Disease"] | — | — | PHASE3 | 1999-03 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000173 | |
| NCT00000174 | NCT00000174 | Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx) | COMPLETED | novartis | This phase IIIb trial is a prospective, randomized, double-blind, placebo-controlled, 36-month study comparing the length of time of progression from mild cognitive impairment (MCI) to a clinical diag… | — | ["Alzheimer Disease","Cognition Disorders"] | — | — | PHASE3 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000174 | |
| NCT00000176 | NCT00000176 | Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women. | COMPLETED | national-institute-on-aging-nia | This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease. | 2007-09 | ["Alzheimer Disease","Memory Disorders"] | — | — | PHASE3 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000176 | |
| NCT00000177 | NCT00000177 | Estrogen Hormone Protocol | COMPLETED | national-institute-on-aging-nia | Estrogen is a hormone that is dominant in the female reproductive system. In women, most estrogen is produced by the ovaries. Men produce estrogen by converting testosterone into estrogen. Because thi… | 1999-01 | ["Alzheimer Disease"] | 120 | — | PHASE3 | 1995-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000177 | |
| NCT00000178 | NCT00000178 | Multicenter Trial of Prednisone in Alzheimer's Disease | COMPLETED | national-institute-on-aging-nia | This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or… | — | ["Alzheimer Disease"] | — | — | PHASE3 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000178 | |
| NCT00000179 | NCT00000179 | Agitation in Alzheimer's Disease | COMPLETED | national-institute-on-aging-nia | Agitation affects 70 to 90 percent of patients with AD. Signs of agitation include verbal and physical aggressiveness, irritability, wandering, and restlessness. These behaviors often make caring for … | — | ["Alzheimer Disease"] | — | — | PHASE3 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00000179 | |
| NCT00001235 | NCT00001235 | Biochemical and Genetic Studies in Familial Alzheimer's Disease | COMPLETED | national-institute-of-neurological-disorders-and-stroke-ninds | Alzheimer's disease is a condition marked by the deterioration of mental function. The disease usually begins in late middle life and results in death in 5 to 10 years. Patients with Alzheimer's disea… | 2004-02 | ["Alzheimer's Disease","Nervous System Disease"] | 1500 | — | — | 1988-02 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00001235 | |
| NCT00001480 | NCT00001480 | The Evaluation and Follow-up of Patients With Memory Disorder and Normal Controls | COMPLETED | national-institute-of-mental-health-nimh | The purpose of this study is to evaluate people with mild memory problems, those with dementia, those at risk for developing Alzheimer's disease (AD), and healthy volunteers to identify markers of AD … | 2007-03-31 | ["Alzheimer's Disease","Dementia","Healthy","Memory Disorder"] | 750 | — | — | 1995-03-21 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00001480 | |
| NCT00001549 | NCT00001549 | Diagnosis and Natural History Protocol for Patients With Neurological Conditions | COMPLETED | national-institute-of-neurological-disorders-and-stroke-ninds | The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics t… | 2006-01 | ["Alzheimer's Disease","Dementia","Movement Disorder","Multiple System Atrophy","Parkinson's Disease"] | 600 | — | — | 1995-10 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00001549 | |
| NCT00001662 | NCT00001662 | Tolerability and Primary Efficacy of CX516 in Alzheimer's Disease | COMPLETED | national-institute-of-neurological-disorders-and-stroke-ninds | Glutamate is an amino acid released by brain cells that acts to excite other cells. Glutamate attaches to special sites on cells called AMPA (alpha-amino-2,3-dihydro-5 methyl 3-oxo-4-isoxazolepropanoi… | 2005-11 | ["Alzheimer's Disease","Dementia"] | 40 | — | PHASE2 | 1996-12 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00001662 | |
| NCT00001917 | NCT00001917 | M2 Receptor Measurements in Aging and in Alzheimer's Disease | COMPLETED | national-institute-of-mental-health-nimh | The purpose of this study is to use brain imaging technology to study the effects of aging and Alzheimer's Disease (AD) on a specific type of brain receptor. The brain is made up of cells called neur… | 2005-04 | ["Alzheimer's Disease","Healthy"] | 150 | — | — | 1999-04 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00001917 | |
| NCT00001933 | NCT00001933 | Nefiracetam Therapy of Alzheimer's Type Dementia | COMPLETED | national-institute-of-neurological-disorders-and-stroke-ninds | Some of the thinking difficulties of Alzheimer's patients may be due to a deficiency in a brain chemical called acetylcholine, which helps transmit messages between nerve cells. Nefiracetam is a new d… | 2002-01 | ["Alzheimer's Disease"] | 50 | — | PHASE2 | 1999-07 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00001933 | |
| NCT00001972 | NCT00001972 | Positron Emission Tomography Imaging of Human Brain Phospholipid Metabolism in Relation to Age and Disease | COMPLETED | national-institute-of-neurological-disorders-and-stroke-ninds | The main source of energy for the brain comes from a combination of oxygen and glucose (sugar). For brain cells to function normally they must receive a constant supply of these nutrients. As areas of… | 2002-08 | ["Alzheimer's Disease","Brain Neoplasm","Niemann Pick Disease"] | 123 | — | — | 1994-09 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00001972 | |
| NCT00001977 | NCT00001977 | Cholinergic Modulation of Human Memory and Attention: Functional Neuroimaging Studies | COMPLETED | national-institute-of-mental-health-nimh | This study will examine whether enhancing the chemical acetylcholine in the brain can improve memory and attention. It will identify changes in brain function that occur during these cognitive tasks. … | 2001-04 | ["Alzheimer's Disease","Healthy"] | 70 | — | — | 2000-01 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00001977 | |
| NCT00004845 | NCT00004845 | A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease | COMPLETED | national-institute-on-aging-nia | The primary specific aim of this clinical trial is to determine whether treatment with rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in patients with Alzheimer… | 2001-12 | ["Alzheimer Disease"] | — | — | PHASE2, PHASE3 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00004845 | |
| NCT00006176 | NCT00006176 | Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies | COMPLETED | national-human-genome-research-institute-nhgri | The purpose of this study is to learn more about the medical problems and the genetic factors involved in a recently defined form of inherited dementia called "familial dementia with neuroserpin inclu… | 2009-08-04 | ["Familial Dementia With Neuroserpin Inclusion Bodies","Nervous System Heredodegenerative Disorder"] | 100 | — | — | 2000-08-10 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00006176 | |
| NCT00006399 | NCT00006399 | Estrogen Modulation Effects on Cholinergic Function in Normal Post-Menopausal Women and Patients With Alzheimer's Disease | COMPLETED | national-center-for-research-resources-ncrr | The goal of this study is to examine whether the administration of estrogen to post-menopausal women and women with mild to moderate Alzheimer's disease will enhance their memory and their capacity fo… | 2004-03 | ["Alzheimer Disease"] | 45 | — | PHASE2 | 1999-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00006399 | |
| NCT00007189 | NCT00007189 | Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) | COMPLETED | seattle-institute-for-biomedical-and-clinical-research | The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory medications naproxen and celecoxib to delay or prevent the onset of AD and age-related cognitive decline. | — | ["Alzheimer Disease"] | 2625 | — | PHASE3 | 2001-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00007189 | |
| NCT00009191 | NCT00009191 | The Depression in Alzheimer's Disease Study (DIADS) | COMPLETED | johns-hopkins-university | Major depression afflicts approximately 25 percent of patients with AD. Depression in AD patients leads to mental suffering, behavioral disturbance (such as aggression), poor cognition, poor self-care… | 2007-11 | ["Alzheimer Disease","Depression"] | — | — | PHASE4 | 2005-11 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00009191 | |
| NCT00009204 | NCT00009204 | Serotonergic Pharmacotherapy for Agitation of Dementia | COMPLETED | bruce-pollock | This study is a randomized, double-blind, placebo-controlled, fixed dose study currently being conducted on two geropsychiatric units at Western Psychiatric Institute and Clinic. It seeks to evaluate … | 2002-04 | ["Dementia","Alzheimer Disease","Dementia, Vascular"] | — | — | PHASE3 | 1995-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00009204 | |
| NCT00009217 | NCT00009217 | Treatment of Behavioral Symptoms in Alzheimer's Disease | COMPLETED | new-york-state-psychiatric-institute | The optimal strategy for the treatment of behavioral complications in patients with probable Alzheimer's disease (AD) remains unclear. The objective of this study is to evaluate the risk of relapse f… | 2004-12 | ["Alzheimer's Disease","Psychosis","Agitation"] | 44 | ACTUAL | PHASE4 | 1999-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00009217 | |
| NCT00010803 | NCT00010803 | Ginkgo Biloba Prevention Trial in Older Individuals | COMPLETED | national-center-for-complementary-and-integrative-health-nccih | This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and functional disability, … | 2011-07 | ["Dementia","Alzheimer's Disease"] | 3069 | ACTUAL | PHASE3 | 2000-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00010803 | |
| NCT00012831 | NCT00012831 | Nurse Managed Clinic for Dementia Patients and Family Caregivers | COMPLETED | us-department-of-veterans-affairs | This study evaluates the effectiveness of a nurse-managed interdisciplinary (nursing and occupational therapy) clinic serving community dwelling dementia patients and their spouse caregivers. It is gr… | 2001-06 | ["Alzheimer's Disease","Caregivers","Dementia"] | 120 | ESTIMATED | — | — | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00012831 | |
| NCT00012857 | NCT00012857 | Pain Management and Behavioral Outcomes in Patients With Dementia | COMPLETED | us-department-of-veterans-affairs | Dementia illness often co-exists with painful medical conditions associated with aging (e.g., degenerative joint disease, osteoarthritis, skin ulcers, back pain, headaches, cancer, or angina). While t… | 2001-03 | ["Dementia","Alzheimer Disease, Pain","Behavior, Agitation"] | 66 | ESTIMATED | PHASE2 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00012857 | |
| NCT00013182 | NCT00013182 | Effect of Activity on Sleep of Cognitively-Impaired Veterans | COMPLETED | us-department-of-veterans-affairs | Sleep-activity rhythm disturbance is a prevalent, disabling symptom in cognitively-impaired (CI) elders. Their nocturnal sleep is light and inefficient with frequent awakenings. Multiple short daytime… | 2001-06 | ["Alzheimer's Disease","Sleep Disorders"] | 90 | ESTIMATED | NA | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00013182 | |
| NCT00013650 | NCT00013650 | Pilot Study of Immunomodulatory Versus Antiinflammatory Therapy in Alzheimer's Disease | COMPLETED | national-institute-of-mental-health-nimh | The purpose of this study is to evaluate the effects of the drug cyclophosphamide (CY) on inflammation and immune responses in individuals with Alzheimer's Disease (AD). Inflammation and immunologic … | 2008-04-21 | ["Alzheimer's Disease"] | 60 | — | PHASE1 | 2001-03-22 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00013650 | |
| NCT00013923 | NCT00013923 | A Nutritional Brain Metabolic Enhancer for Alzheimer Disease | COMPLETED | national-institute-on-aging-nia | The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease. | 2005-06 | ["Alzheimer Disease"] | 40 | — | PHASE2 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00013923 | |
| NCT00015548 | NCT00015548 | Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer's Disease (CATIE Alzheimer's Disease Trial) | COMPLETED | national-institute-of-mental-health-nimh | The CATIE Alzheimer's Disease Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project. The study is for people with Alzheimer's disease who are having trouble … | 2004-10 | ["Alzheimer's Disease"] | 450 | — | NA | 2001-03 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00015548 | |
| NCT00017940 | NCT00017940 | A Phase I Study of Ex Vivo Nerve Growth Factor Gene Therapy for Alzheimer's Disease | COMPLETED | the-shiley-family-trust | This Phase I clinical trial is the first step in testing gene therapy. This study is called a "Safety/Toxicity" study by the Food and Drug Administration, and primarily aims to determine whether the e… | 2003-11 | ["Alzheimer Disease"] | 8 | — | PHASE1 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00017940 | |
| NCT00018278 | NCT00018278 | Verbal Memory ERPs as Indices of Treatment Response in Alzheimer Disease | COMPLETED | us-department-of-veterans-affairs | The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to… | 2001-09 | ["Alzheimer Disease"] | — | — | PHASE4 | 1998-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00018278 | |
| NCT00018291 | NCT00018291 | Specific Interventions for Agitation in Alzheimer's Disease | COMPLETED | us-department-of-veterans-affairs | This study is aimed at investigating specific pharmacological interventions in the treatment of the disruptive, agitated behavior associated with Alzheimer's patients. In addition, it is hoped that sp… | 2005-01 | ["Alzheimer's Disease","Dementia"] | — | — | NA | 2001-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00018291 | |
| NCT00018343 | NCT00018343 | Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen | COMPLETED | us-department-of-veterans-affairs | This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease. | 2001-03 | ["Alzheimer's Disease"] | — | — | PHASE2 | 1998-04 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00018343 | |
| NCT00018382 | NCT00018382 | Insulin, Neurogenetics and Memory in Alzheimer's Disease: A Novel Therapeutic Approach | COMPLETED | us-department-of-veterans-affairs | This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease. | 2003-03 | ["Alzheimer Disease"] | — | — | PHASE2 | 1999-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00018382 | |
| NCT00018473 | NCT00018473 | Gene-Environment Interactions in Alzheimer's Disease | COMPLETED | us-department-of-veterans-affairs | This study will create Alzheimer 's disease risk profiles for defined combinations of genotypes and environmental exposures. This study will carry out a molecular epidemiologic study to identify genet… | 2004-03 | ["Alzheimer's Disease"] | — | — | — | 1999-04 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00018473 | |
| NCT00024531 | NCT00024531 | Effect of the HMG-CoA Reductase Inhibitor Atorvastatin Calcium, Lipitor, in the Treatment of Alzheimer's Disease | COMPLETED | institute-for-the-study-of-aging-isoa | The purpose of this study is to assess the clinical benefit of Lipitor, a cholesterol-lowering drug, in the treatment of Alzheimer's disease. | 2004-08 | ["Alzheimer Disease"] | 98 | — | PHASE2 | 2000-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00024531 | |
| NCT00029120 | NCT00029120 | MRI Contrast Imaging in the Evaluation and Follow-up of Patients With Memory Disorder and Healthy Controls | COMPLETED | national-institute-of-mental-health-nimh | The purpose of this study is to examine how a part of the brain called the hippocampus contributes to memory changes that occur with aging and Alzheimer's disease (AD). Memory problems are the most i… | 2008-04-21 | ["Alzheimer Disease","Dementia","Memory Disorder","Healthy"] | 450 | — | — | 2001-12-18 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00029120 | |
| NCT00034567 | NCT00034567 | Alzheimer's Disease Prevention Instrument Protocol | COMPLETED | national-institute-on-aging-nia | This project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in Alzheimer's Disease (AD) primary prevention trials. | — | ["Alzheimer Disease"] | 650 | — | — | — | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00034567 | |
| NCT00034762 | NCT00034762 | Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer's Disease. | COMPLETED | johnson-johnson-pharmaceutical-research-development-l-l-c | The purpose of this study is to evaluate the efficacy and safety of risperidone compared with placebo in the treatment of psychotic symptoms in patients with Alzheimer's disease | 2003-01 | ["Dementia","Alzheimer Disease","Mental Disorders"] | 473 | ACTUAL | PHASE3 | 2000-12 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00034762 | |
| NCT00035204 | NCT00035204 | A Double-blind, Randomized Pilot Study to Evaluate the Effects of Galantamine and Donepezil on Sleep and Attention and Gastrointestinal (GI) Tolerance in Patients With Mild to Moderate Alzheimer's Dis… | COMPLETED | johnson-johnson-pharmaceutical-research-development-l-l-c | The purpose of this study is to evaluate the relative effects of galantamine compared to donepezil (both cholinesteraste inhibitors), on sleep, attention, and gastrointestinal tolerance in patients wi… | 2003-05 | ["Alzheimer Disease"] | 63 | ACTUAL | PHASE4 | — | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00035204 | |
| NCT00036114 | NCT00036114 | Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type | COMPLETED | otsuka-pharmaceutical-development-commercialization-inc | The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type. | 2003-08 | ["Alzheimer Disease"] | — | — | PHASE3 | 2000-03 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00036114 | |
| NCT00039702 | NCT00039702 | SPECT Imaging of Alpha4beta2 Nicotinic Acetylcholine Receptors Using [123I]5-I-A-85380 in Alzheimer's Disease | COMPLETED | national-institute-of-mental-health-nimh | The purpose of this study is to use brain imaging technology to examine the role of certain brain chemicals in individuals with Alzheimer's disease (AD) and in healthy volunteers. Cognitive dysfuncti… | 2004-09 | ["Alzheimer Disease"] | 40 | — | — | 2002-06 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00039702 | |
| NCT00040378 | NCT00040378 | Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) | COMPLETED | frederick-schmitt | The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). As a prevention tr… | 2016-08 | ["Alzheimer Disease"] | 4246 | ACTUAL | — | 2002-05 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00040378 | |
| NCT00040443 | NCT00040443 | Efficacy And Safety Of CX516 (900 mg t.i.d.) In Elderly Participants With Mild Cognitive Impairment. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group 4-week Study. | COMPLETED | respirerx | Glutamate is fundamentally involved in learning and memory. Memory loss associated with mild cognitive impairment may be due to loss of glutamate receptors in the aging brain. There is evidence CX516 … | 2004-06 | ["Mild Cognitive Impairment"] | 175 | ACTUAL | PHASE2 | 2002-04 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00040443 | |
| NCT00041678 | NCT00041678 | Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type | COMPLETED | otsuka-pharmaceutical-development-commercialization-inc | The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type. | 2003-03 | ["Alzheimer Disease"] | — | — | PHASE3 | 2000-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00041678 | |
| NCT00042172 | NCT00042172 | Cognitive Enhancers Explored With PET Imaging | COMPLETED | university-of-iowa | The purpose of this study is to evaluate the effectiveness of donepezil (Aricept) for the treatment of mild cognitive impairment (MCI) in elderly adults. This study will also determine whether adding … | 2004-09 | ["Cognition Disorders","Alzheimer Disease"] | 40 | — | PHASE4 | 2002-06 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00042172 | |
| NCT00046358 | NCT00046358 | The Effect of Short-Term Statin and NSAID Treatment on CSF Beta-Amyloid | COMPLETED | national-institute-of-mental-health-nimh | The purpose of this study is to determine whether short-term use of the drugs ibuprofen and lovastatin affects levels of a protein called beta-amyloid in people who are at risk for developing Alzheime… | 2005-08 | ["Alzheimer Disease"] | 50 | — | PHASE4 | 2002-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00046358 | |
| NCT00051909 | NCT00051909 | Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease | COMPLETED | eli-lilly-and-company | Study of an investigational medication for the treatment of Alzheimer's Disease in patients who are not taking Aricept, Reminyl, Exelon. | 2003-06 | ["Alzheimer's Disease"] | 200 | — | PHASE2 | 2002-11 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00051909 | |
| NCT00053599 | NCT00053599 | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Slow the Progression of Alzheimer's Disease | COMPLETED | national-institute-on-aging-nia | CLASP is a research study to investigate the safety and effectiveness of simvastatin (a cholesterol lowering drug or statin) to slow the progression of Alzheimer's disease (AD). Statins are commonly u… | 2007-10 | ["Alzheimer Disease"] | 400 | — | PHASE3 | 2002-12 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00053599 | |
| NCT00056225 | NCT00056225 | High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL) | COMPLETED | national-institute-on-aging-nia | The purpose of this study is to determine whether reduction of homocysteine levels with high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive decline in persons wi… | 2007-06 | ["Alzheimer's Disease"] | 340 | ACTUAL | PHASE3 | 2003-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00056225 | |
| NCT00056316 | NCT00056316 | Reducing Depression in Dementia Caregivers | COMPLETED | university-of-missouri-st-louis | The purpose of this study was to develop and examine the initial impact of a distance-based intervention for female family dementia caregivers. As stated in the original proposal, the primary hypothes… | 2004-08 | ["Depression"] | 74 | ACTUAL | PHASE1, PHASE2 | 2002-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00056316 | |
| NCT00056524 | NCT00056524 | An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect. | COMPLETED | avanir-pharmaceuticals | The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect (episodes of uncontrolle… | 2007-06 | ["Alzheimer's Disease","Stroke","Parkinson's Disease","Traumatic Brain Injury"] | 600 | ESTIMATED | PHASE3 | 2003-02 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00056524 | |
| NCT00056628 | NCT00056628 | Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System | COMPLETED | eunoe | This is a study of the effect on the progression of Alzheimer's Disease of a surgically implanted shunt (tube) to increase the flow of cerebrospinal fluid and improve the clearance of potential neurot… | 2004-10 | ["Alzheimer Disease"] | 250 | — | PHASE3 | 2001-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00056628 | |
| NCT00059410 | NCT00059410 | Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II | COMPLETED | alzheimer-s-association | The TIPS Study, or Treatment and Illness Perceptions Survey, is a study funded by the national Alzheimer's Association to learn more about differences between African Americans' and Whites' attitudes,… | 2005-09 | ["Alzheimer Disease"] | 210 | — | — | 2003-01 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00059410 | |
| NCT00062569 | NCT00062569 | Reminiscence During Bathing Persons With Alzheimer's Disease at Home | COMPLETED | national-institute-of-nursing-research-ninr | This study will evaluate the effectiveness of a 3-week reminiscence intervention applied during bathing persons with Alzheimer's disease (AD) in decreasing resistiveness to care (RTC), relieving patie… | 2006-06 | ["Alzheimer Disease"] | 90 | ACTUAL | NA | 2002-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00062569 | |
| NCT00063310 | NCT00063310 | Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) | COMPLETED | voyager-pharmaceutical-corporation | ALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a hormone drug) to improve the cognitive function and slow the progression of Alzheimer's disease (AD). In women … | 2006-02 | ["Alzheimer Disease"] | 90 | — | PHASE2 | 2003-03 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00063310 | |
| NCT00064870 | NCT00064870 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | RECRUITING | indiana-university | The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset … | 2026-07 | ["Alzheimer Disease","Late Onset Alzheimer Disease","Dementia"] | 10000 | ESTIMATED | — | 2002-06 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00064870 | |
| NCT00065169 | NCT00065169 | Anti-Inflammation in AD: PET Imaging Supplement | COMPLETED | university-of-california-los-angeles | The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study … | 2005-11 | ["Alzheimer Disease","Dementia"] | 138 | — | NA | 2000-11 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00065169 | |
| NCT00065689 | NCT00065689 | High Intensity Light Therapy in Alzheimer's Disease | COMPLETED | national-center-for-complementary-and-integrative-health-nccih | The purpose of this study is to determine whether bright light improves the sleep, mood, and behavior of persons with Alzheimer's disease and related dementias (AD) who live in long-term care settings… | 2005-09 | ["Alzheimer's Disease","Dementia"] | 107 | — | PHASE3 | 2003-03 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00065689 | |
| NCT00065767 | NCT00065767 | Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease | COMPLETED | university-of-wisconsin-madison | The aim of this study is to determine the effectiveness of treatment with raloxifene, an estrogen-like medication approved by the Food and Drug Administration for the treatment of osteoporosis, in imp… | 2005-03 | ["Alzheimer Disease"] | 20 | — | PHASE2, PHASE3 | 2001-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00065767 | |
| NCT00066157 | NCT00066157 | Alzheimer's Disease: Therapeutic Potential of Estrogen | COMPLETED | university-of-wisconsin-madison | This is a 15-month study to determine the effectiveness of hormone replacement therapy in improving memory and the ability to live independently in postmenopausal women with Alzheimer's disease. | 2007-12 | ["Alzheimer Disease"] | 42 | ACTUAL | PHASE2, PHASE3 | 2001-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00066157 | |
| NCT00071721 | NCT00071721 | A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD) | COMPLETED | alzheimer-s-disease-cooperative-study-adcs | The purpose of this trial is to demonstrate whether valproate therapy delays the emergence of agitation and/or psychosis in outpatients with probable Alzheimer's disease (AD) who have not experienced … | 2009-12 | ["Alzheimer Disease"] | 313 | ACTUAL | PHASE3 | 2003-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00071721 | |
| NCT00073658 | NCT00073658 | Continuation Pharmacotherapy for Agitation of Dementia | COMPLETED | university-of-pittsburgh | This study will compare the safety and effectiveness two medications, citalopram (Celexa®) and risperidone (Risperdal®). | 2005-06 | ["Dementia"] | 137 | — | PHASE2 | 2000-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00073658 | |
| NCT00074529 | NCT00074529 | A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of MK-0677 25 mg in Slowing the Progression of Alzheimer's Disease | COMPLETED | merck-sharp-dohme-llc | An investigational drug (MK0677) will be studied to determine whether it helps the memory and cognition of patients with Alzheimer's Disease. | 2006-01 | ["Alzheimer's Disease"] | 512 | ACTUAL | PHASE2 | 2003-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00074529 | |
| NCT00076440 | NCT00076440 | Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study | COMPLETED | voyager-pharmaceutical-corporation | ALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a hormone drug) to improve the cognitive function and slow the progression of Alzheimer's disease (AD) in men 65 … | 2007-03 | ["Alzheimer Disease"] | 90 | — | PHASE2 | 2003-12 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00076440 | |
| NCT00082602 | NCT00082602 | Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer's Disease | COMPLETED | johnson-johnson-pharmaceutical-research-development-l-l-c | The purpose of this study is to evaluate the safety and tolerability of an extended release formulation of the drug galantamine using a rapid dose escalation regimen. | 2005-04 | ["Alzheimer's Disease"] | 83 | ACTUAL | PHASE3 | 2004-05 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00082602 | |
| NCT00083421 | NCT00083421 | Effects of ONO-2506PO in Patients With Alzheimer's Disease | COMPLETED | ono-pharma-usa-inc | The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales. | 2007-07 | ["Alzheimer's Disease"] | 647 | ACTUAL | PHASE2 | 2004-06 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00083421 | |
| NCT00083590 | NCT00083590 | A Multi-Center, Double-Blind, Placebo-Controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function | COMPLETED | national-institute-on-aging-nia | The present study will evaluate the safety and efficacy of the Chinese herb huperzine A in the treatment of Alzheimer's disease (AD) in a randomized controlled trial of its effect on cognitive functio… | 2007-11 | ["Alzheimer Disease"] | 150 | ESTIMATED | PHASE2 | 2004-04 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00083590 | |
| NCT00086138 | NCT00086138 | Depression in Alzheimer's Disease (DIADS-2) | COMPLETED | johns-hopkins-university | The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's… | 2009-07 | ["Alzheimer's Disease","Depression"] | 131 | ACTUAL | PHASE2, PHASE3 | 2004-07 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00086138 | |
| NCT00087789 | NCT00087789 | A Phase I, Dose-Escalating Study to Assess the Safety and Tolerability of CERE-110 [Adeno-Associated Virus (AAV)-Based Vector-Mediated Delivery of Beta-Nerve Growth Factor (NGF)] in Subjects With Mild… | COMPLETED | sangamo-therapeutics | This is a Phase I clinical study to assess the safety, tolerability and biologic activity of in vivo AAV-mediated delivery of CERE-110. Up to 12 subjects will receive open label CERE-110 in dose-escal… | 2010-05 | ["Alzheimer's Disease"] | 10 | ACTUAL | PHASE1 | 2004-06 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00087789 | |
| NCT00088387 | NCT00088387 | Glycogen Synthetase Kinase 3 (GSK-3) Inhibition in Alzheimer's Disease | COMPLETED | national-institute-of-neurological-disorders-and-stroke-ninds | This study will examine the effect of the drugs lithium and divalproex (Depakote) on tau proteins, a type of protein in the brain and spinal fluid that are altered in patients with Alzheimer's disease… | 2005-03 | ["Alzheimer Disease"] | 35 | — | PHASE2 | 2004-07 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00088387 | |
| NCT00088751 | NCT00088751 | Treatment Study for Frontotemporal Dementia | COMPLETED | national-institute-of-neurological-disorders-and-stroke-ninds | Objectives. The proposed clinical study has two goals: First, to assess the efficacy of a central nervous system stimulant and an atypical antipsychotic in treating the behavioral symptoms of FTD and … | 2009-06-01 | ["Frontotemporal Lobar Degeneration"] | 20 | — | — | 2004-07-23 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00088751 | |
| NCT00089882 | NCT00089882 | Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II | COMPLETED | national-institute-on-aging-nia | The REVEAL II study provides healthy adult children and siblings of Alzheimer's disease patients with genetic testing and information about their own chances of developing the disease. The study will … | 2006-09 | ["Alzheimer Disease"] | 360 | — | — | 2003-05 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00089882 | |
| NCT00090116 | NCT00090116 | A Randomized, Double-Blind,Placebo-Controlled Evaluation of the Safety and Efficacy of Neramexane Monotherapy in Patients With Moderate to Severe Dementia of the Alzheimer's Type | COMPLETED | forest-laboratories | Memory loss and difficulties with thinking associated with Alzheimer's disease may be due to chronic release of a brain chemical called glutamate. Glutamate helps transmit messages between nerve cells… | 2005-03 | ["Alzheimer's Disease"] | 400 | — | PHASE3 | 2003-03 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00090116 | |
| NCT00090402 | NCT00090402 | Fish Oil and Alpha Lipoic Acid in Mild Alzheimer's Disease | COMPLETED | oregon-health-and-science-university | The purpose of this study is to determine the effect of fish oil and the antioxidant alpha lipoic acid on factors in the blood that are associated with the progression of Alzheimer's Disease (AD). | 2007-08 | ["Alzheimer's Disease","Oxidative Stress","Dementia","Hyperlipidemia","Inflammation"] | 39 | ACTUAL | PHASE1, PHASE2 | 2004-04 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00090402 | |
| NCT00093951 | NCT00093951 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study of the Efficacy and Safety of SGS742 in Subjects With Mild to Moderate Alzheimer's Disease | COMPLETED | saegis-pharmaceuticals | The purpose of this trial is to determine the effect of a new drug, SGS742, on memory and cognition in patients with mild to moderate Alzheimer's disease. | 2007-09 | ["Alzheimer's Disease"] | 280 | — | PHASE2 | 2004-04 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00093951 | |
| NCT00095719 | NCT00095719 | A Safety & Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia | COMPLETED | otsuka-pharmaceutical-development-commercialization-inc | The purpose of this trial is to test the safety \& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia. | 2005-03 | ["Dementia","Alzheimer's Disease"] | 125 | — | PHASE3 | 2003-12 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00095719 | |
| NCT00096473 | NCT00096473 | A 24 Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Donepezil Hydrochloride (E2020) in Patients With Severe Alzheimer's Disease Followed by a … | COMPLETED | eisai-inc | Donepezil hydrochloride (Aricept) has been approved to treat symptoms associated with mild to moderate Alzheimer's disease (AD). Aricept has been shown to improve the memory and thinking abilities, ac… | 2005-09 | ["Alzheimer's Disease","Dementia"] | 229 | ACTUAL | PHASE3 | 2001-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00096473 | |
| NCT00097916 | NCT00097916 | A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Non-Institutionalized Agitated Patients With Moderate to Severe Alzheimer's Disease | COMPLETED | forest-laboratories | About 65% of patients with severe Alzheimer's Disease (AD) will have symptoms of agitation. There are drawbacks associated with the currently available therapeutic interventions for agitation associat… | 2006-04 | ["Alzheimer's Disease"] | 34 | ACTUAL | PHASE3 | 2004-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00097916 | |
| NCT00099242 | NCT00099242 | Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease | COMPLETED | novartis-pharmaceuticals | The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease. | 2006-01 | ["Alzheimer's Disease","Dementia, Alzheimer Type"] | 1040 | — | PHASE3 | 2003-11 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00099242 | |
| NCT00099567 | NCT00099567 | Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline | COMPLETED | national-institute-on-aging-nia | The purpose of this study is to determine if the metabolic syndrome is a risk factor for cognitive decline and if this association is modified by inflammation. | 2002-12 | ["Cognitive Decline"] | 2632 | — | — | 1997-01 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00099567 | |
| NCT00099710 | NCT00099710 | A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Two Doses of Curcumin C3 Complex Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease | COMPLETED | john-douglas-french-foundation | The purpose of this study is to examine the safety and tolerability of curcumin, and to determine its effect on patients with mild to moderate Alzheimer's Disease (AD). | 2007-12 | ["Alzheimer's Disease"] | 33 | ESTIMATED | PHASE2 | 2003-07 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00099710 | |
| NCT00100282 | NCT00100282 | Single Dose Escalation Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease | COMPLETED | praecis-pharmaceuticals-inc | This is a multi-center, double-blind, inpatient study followed by outpatient, placebo-controlled, single-dose, dose-escalation evaluation of the safety and tolerability of PPI-1019 in patients with mi… | 2005-06 | ["Alzheimer's Disease"] | 125 | — | PHASE1 | 2003-05 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00100282 | |
| NCT00100334 | NCT00100334 | Multiple Dose Safety and Preliminary Pharmacodynamic Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease | COMPLETED | praecis-pharmaceuticals-inc | This is a single-center, double-blind, inpatient study followed by an outpatient, placebo-controlled, multiple-IV injection evaluation of the safety and tolerability of PPI-1019 in subjects with mild-… | 2005-08 | ["Alzheimer's Disease"] | 24 | — | PHASE1, PHASE2 | 2004-12 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00100334 | |
| NCT00103649 | NCT00103649 | A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type | COMPLETED | sanofi | The purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's disease. The patient… | 2007-10 | ["Alzheimer Disease"] | 1306 | ACTUAL | PHASE3 | 2003-11 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00103649 | |
| NCT00104013 | NCT00104013 | A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 18-Month Study of the Efficacy of Xaliproden in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type | COMPLETED | sanofi | The purpose of this study is to assess xaliproden's potential capacity of slowing the deterioration of cognitive and global functions in patients with mild to moderate Alzheimer's disease. The patient… | 2007-11 | ["Alzheimer Disease"] | 1455 | ACTUAL | PHASE3 | 2003-11 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00104013 | |
| NCT00104273 | NCT00104273 | A 1-Year, Double-Blind, Randomized, Placebo-Controlled, Study of Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Dementia of the Alzheimer's Type | COMPLETED | teva-branded-pharmaceutical-products-r-d-inc | The purpose of this study is to evaluate the safety, tolerability, and efficacy of two dose levels of rasagiline mesylate versus placebo in patients with mild-to-moderate Alzheimer's Disease who are t… | — | ["Dementia","Alzheimer's Disease"] | 376 | ACTUAL | PHASE2 | 2004-08 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00104273 | |
| NCT00104442 | NCT00104442 | Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease | COMPLETED | novartis | Alzheimer's disease is a medical illness that damages the brain and causes problems with memory, mood and behavior. A substance called acetylcholine (ACh), which is naturally produced in the body, pla… | 2006-04 | ["Alzheimer's Disease"] | 80 | — | PHASE4 | 2003-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00104442 | |
| NCT00105547 | NCT00105547 | Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Study of the Effect of Daily Treatment With MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subj… | COMPLETED | myrexis-inc | The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of… | 2008-05 | ["Alzheimer Disease","Dementia"] | 1600 | ACTUAL | PHASE3 | 2005-02 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00105547 | |
| NCT00105612 | NCT00105612 | Improving Informed Consent in Alzheimer's Disease Research | COMPLETED | national-institute-on-aging-nia | The purpose of this trial is to test whether a memory and organizational aid in the form of a document that summarizes and simplifies a study's key points can improve the decision-making abilities and… | 2007-03 | ["Alzheimer's Disease","Aging"] | 110 | — | NA | 2004-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00105612 | |
| NCT00105638 | NCT00105638 | A Telehealth Education Program for Caregivers of Veterans With Dementia | COMPLETED | us-department-of-veterans-affairs | This study was designed to evaluate the impact of a Telehealth Education Program (TEP) on outpatient veterans with moderate to severe dementia and their spouse caregivers. The TEP is a program of educ… | 2007-04 | ["Dementia","Alzheimer Disease"] | 160 | ESTIMATED | NA | 2005-09 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00105638 | |
| NCT00106899 | NCT00106899 | Alzheimer's Disease Neuroimaging Initiative | COMPLETED | alzheimer-s-disease-cooperative-study-adcs | The purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). This… | 2011-06 | ["Alzheimer's Disease"] | 818 | ACTUAL | — | 2005-07 | OBSERVATIONAL | https://clinicaltrials.gov/study/NCT00106899 | |
| NCT00110552 | NCT00110552 | Effects of a Cognitive Enhancer on Memory and Cognitive Performance | COMPLETED | oregon-health-and-science-university | The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease. Study hypothesis: The administration of sage wil… | 2014-10 | ["Alzheimer Disease"] | 111 | ACTUAL | PHASE1 | 2005-07 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00110552 | |
| NCT00112073 | NCT00112073 | A Phase IIA, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Immunogenicity Trial of AAB-001 in Patients… | COMPLETED | janssen-alzheimer-immunotherapy-research-development-llc | The purpose of this study is to assess the safety and tolerability of multiple doses of AAB-001 passive immunization in patients with mild to moderate Alzheimer's disease (AD). | 2008-12 | ["Alzheimer's Disease"] | 234 | ACTUAL | PHASE2 | 2005-04 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00112073 | |
| NCT00117403 | NCT00117403 | Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease | COMPLETED | national-institute-on-aging-nia | The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include v… | 2007-09 | ["Alzheimer's Disease"] | 75 | ESTIMATED | PHASE1 | 2006-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00117403 | |
| NCT00119561 | NCT00119561 | Testing the Effectiveness of Telephone Support for Dementia Caregivers | COMPLETED | us-department-of-veterans-affairs | The primary goal of the study is documentation of effectiveness of telephone support groups to reduce caregiver burden and stress. Caregivers who participate in intervention (Telephone Support) should… | 2014-01 | ["Dementia","Alzheimer Disease"] | 154 | ACTUAL | NA | 2005-02 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00119561 | |
| NCT00120874 | NCT00120874 | Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial | COMPLETED | nyu-langone-health | The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwellin… | 2011-11 | ["Alzheimer's Disease"] | 20 | ACTUAL | PHASE4 | 2006-08 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00120874 | |
| NCT00130429 | NCT00130429 | Phase II Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Investigate the Safety, Effect on Cognition and Pharmacokinetic Profile of PYM50028 in Subjects With Mild Dementia of the… | COMPLETED | phytopharm | The purpose of this study is to assess the effect of PYM50028 administered once daily for up to 12 weeks on the memory and other faculties of subjects with dementia due to Alzheimer's disease. | 2005-09 | ["Alzheimer's Disease"] | 250 | — | PHASE2 | 2004-01 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00130429 | |
| NCT00141661 | NCT00141661 | A Double-Blind, Randomized, Placebo-Controlled, Phase IIa, Multiple Dose, Multicenter Study in Subjects With Mild to Moderate Dementia of the Alzheimer's Type to Evaluate the Safety and Tolerability o… | COMPLETED | pfizer | A 10-week safety and tolerability study of a potential treatment for mild to moderate Alzheimer's disease. | 2006-06 | ["Alzheimer Disease"] | 67 | ACTUAL | PHASE2 | 2005-10 | INTERVENTIONAL | https://clinicaltrials.gov/study/NCT00141661 |